Afghanistan COVID-19 Emergency Response and Health Systems Preparedness Project

Abstract*

The project will address critical country-level needs for preparedness and response for COVID-19. It will fill critical financing gaps that have been identified due to the new emergency preparedness and response needs created by COVID-19.The project financing amount is US$100.4 million, with US$19.4 million from the World Bank COVID19 Fast-Track Facility and US$81 million from the Afghanistan Regular IDA18 allocation. The combined IDA financing for... Show More

Development Objective

The project development objective is to respond to, and mitigate the threat posed by COVID-19 and strengthen national systems for public health preparedness in Afghanistan.

Key Details

Project Details

Project ID
P173775
Status
Active
Team Leader
Gyorgy Fritsche , Habibullah Ahmadzai
Borrower 2
The Islamic Republic of Afghanistan

Country
Afghanistan
Disclosure Date
April 2, 2020
Approval Date
(as of board presentation)
April 2, 2020
Effective Date
April 12, 2020

Total Project Cost 1
US$ 100.40 million
Implementing Agency
Ministry of Public Health
Region
South Asia
Fiscal Year 3
2020

Commitment Amount
US$ 100.40 million
Environmental Category
N/A
Environmental and Social Risk
High
Closing Date
June 30, 2025

Consultant Services required
Yes
Last Stage Reached
BANK APPROVED
Last Update Date
April 30, 2024

Associated Projects
P176012

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Human Development and Gender

FY17 - Disease Control100%
- FY17 - Pandemic Response100%
FY17 - Health Systems and Policies100%
- FY17 - Health Finance51%
- FY17 - Health Service Delivery5%
- FY17 - Health System Strengthening100%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
IDA Grant	100.40

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	N/A
IDA Commitment	100.40
IBRD + IDA Commitment	100.40

Lending Instrument
Grant Amount	N/A
Total Project Cost**	100.40

Summary Status of World Bank Financing (US$ Millions) as of April 30, 2025

No data available.

Detailed Financial Activity as of April 30, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
Apr 2, 2020	IDA-D5930	Loan Commitment	100,400,000.00
Mar 18, 2021	IDA-D7810	Loan Commitment	60,000,000.00
Feb 4, 2022	IDA-D5930	Loan Disb	827,144.30
Feb 4, 2022	IDA-D5930	Loan Disb	835,145.80
Feb 4, 2022	IDA-D5930	Loan Disb	256,167.90
Feb 4, 2022	IDA-D5930	Loan Disb	1,255,499.50
Feb 4, 2022	IDA-D5930	Loan Disb	573,439.75
Feb 16, 2022	IDA-D5930	Loan Disb	669,455.75
Feb 16, 2022	IDA-D5930	Loan Disb	2,221,331.50
Feb 16, 2022	IDA-D5930	Loan Disb	757,191.06
Feb 16, 2022	IDA-D5930	Loan Disb	773,470.75
Feb 4, 2022	IDA-D5930	Loan Disb	425,107.75
Feb 4, 2022	IDA-D5930	Loan Disb	300,951.06
Feb 16, 2022	IDA-D5930	Loan Disb	1,387,640.20
Feb 4, 2022	IDA-D5930	Loan Disb	280,976.10
Feb 16, 2022	IDA-D5930	Loan Disb	302,137.16
Feb 16, 2022	IDA-D5930	Loan Disb	455,833.34
Feb 16, 2022	IDA-D5930	Loan Disb	316,213.53
Feb 4, 2022	IDA-D5930	Loan Disb	902,335.30
Feb 4, 2022	IDA-D5930	Loan Disb	558,789.56
Feb 4, 2022	IDA-D5930	Loan Disb	1,237,066.40
Dec 22, 2022	IDA-D5930	Loan Disb	-2,594,221.80
Feb 10, 2022	IDA-D5930	Loan Disb	8,421.50
Feb 4, 2022	IDA-D5930	Loan Disb	16,457.72
Jan 21, 2022	IDA-D5930	Loan Disb	1,433,110.90
Feb 4, 2022	IDA-D5930	Loan Disb	16,037.27
Feb 4, 2022	IDA-D5930	Loan Disb	23,968.68
Feb 10, 2022	IDA-D5930	Loan Disb	8,813.84
Feb 10, 2022	IDA-D5930	Loan Disb	12,705.48
Feb 10, 2022	IDA-D5930	Loan Disb	38,677.79
Feb 4, 2022	IDA-D5930	Loan Disb	35,503.81
Feb 4, 2022	IDA-D5930	Loan Disb	23,739.05
Feb 4, 2022	IDA-D5930	Loan Disb	8,637.31
Feb 4, 2022	IDA-D5930	Loan Disb	12,200.60
Feb 15, 2022	IDA-D5930	Loan Disb	59,838.38
Feb 15, 2022	IDA-D5930	Loan Disb	253,676.77
Feb 10, 2022	IDA-D5930	Loan Disb	21,559.00
Feb 10, 2022	IDA-D5930	Loan Disb	18,659.78
Feb 10, 2022	IDA-D5930	Loan Disb	21,105.23
Dec 9, 2021	IDA-D5930	Loan Disb	545,890.75
Feb 4, 2022	IDA-D5930	Loan Disb	25,897.03
Feb 10, 2022	IDA-D5930	Loan Disb	61,915.31
Apr 8, 2021	IDA-D5930	Loan Disb	16,500,714.00
Nov 24, 2020	IDA-D5930	Loan Disb	13,086.82
Nov 24, 2020	IDA-D5930	Loan Disb	8,853.37
Sep 15, 2020	IDA-D5930	Loan Disb	3,741,930.00
May 21, 2020	IDA-D5930	Loan Disb	23,000,000.00
Apr 13, 2020	IDA-D5930	Loan Disb	20,000,000.00

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name	Review	Date
Procurement	Moderately Unsatisfactory	2023-12-01
Project Management	Moderately Satisfactory	2023-12-01
Overall Implementation Progress (IP)	Moderately Unsatisfactory	2023-12-01
Progress towards achievement of PDO	Moderately Satisfactory	2023-12-01
Financial Management	Moderately Satisfactory	2023-12-01
Monitoring and Evaluation	Satisfactory	2023-12-01

COMPLETION RATINGS

INDICATOR	IMPLEMENTATION COMPLETION & RESULTS REPORT: 11-13-2022
Outcomes	Moderately Unsatisfactory
Risk to Development Outcome
Bank Performance	Substantial
Borrower Performance
Government Performance
Implementing Agency

INDEPENDENT EVALUATION RATINGS

INDICATOR	ICR REVIEW: 04-26-2023	PROJECT PERFORMANCE ASSESSMENT REPORT:
Outcome Rating	Moderately Unsatisfactory	N/a
Risk To Development Outcome		N/a
Bank Performance	Satisfactory	N/a
Borrower Performance		N/a
Government Performance		N/a
Implementing Agency		N/a
Icr Quality	High	N/a
M&e Quality	Substantial	N/a

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Number of health workers who are fully vaccinated against COVID-19 Value 0.00 50000.00 0.00
Date January 11, 2021 March 31, 2024
Comment
Percentage of population vaccinated, which is included in the priority population targets defined in national plan [by gender]. Value 0.00 48.00 0.00
Date January 15, 2021 March 31, 2024
Comment
Proportion of hospitals contracted for COVID-19 treatment with adequate personal protective equipment Value 0.00 70.00 0.00
Date April 1, 2020 March 31, 2024
Comment
Proportion of hospitals contracted for COVID-19 treatment with adequate isolation treatment available Value 0.00 70.00 0.00
Date April 1, 2020 March 31, 2024
Comment

INTERMEDIATE RESULTS INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Proportion of provincial hospital doctors and nurses who are trained on WHO standards of clinical treatment for COVID-19 Value 0.00 80.00 0.00
Date March 31, 2020 March 31, 2024
Comment
Community engagement plan implemented for increasing demand creation for the Covid-19 vaccine by the population Value No Yes
Date January 11, 2021 March 31, 2024
Comment
Percentage of EPI fixed vaccination centers with a female staff present Value 98.00 100.00 0.00
Date January 14, 2021 March 31, 2024
Comment
Proportion of specimens submitted for COVID-19 virus laboratory testing with results available within 48 hours Value 0.00 50.00 0.00
Date April 1, 2020 March 31, 2024
Comment
Proportion of vaccines not wasted Value 0.00 90.00 0.00
Date January 11, 2021 March 31, 2024
Comment
Percentage of health facilities in the project area with functioning management committees having community representation Value 80.00 95.00 0.00
Date January 11, 2021 March 31, 2024
Comment
Proportion of identified contacts who are successfully traced Value 0.00 70.00 0.00
Date March 31, 2020 March 31, 2024
Comment
Percentage of grievances resolved within a month of their receipt Value 0.00 70.00 0.00
Date January 11, 2021 March 31, 2024
Comment
Presence of a Biosafety Level 2 facility in each of 5 regions Value 0.00 70.00 100.00
Date March 31, 2020 March 31, 2024 March 31, 2024
Comment
Number of solarized cold storage and health facilities Value 605.00 2234.00 0.00
Date February 11, 2021 March 31, 2024
Comment
Proportion of population able to identify three key symptoms of COVID-19 and three personal prevention measures Value 0.00 60.00 0.00
Date April 1, 2020 March 31, 2024
Comment
National plan developed for COVID-19 vaccine procurement and deployment Value No Yes
Date January 11, 2021 March 31, 2024
Comment

Number of health workers who are fully vaccinated against COVID-19	Value	0.00	50000.00	0.00
	Date	January 11, 2021	March 31, 2024
	Comment

Percentage of EPI fixed vaccination centers with a female staff present	Value	98.00	100.00	0.00
	Date	January 14, 2021	March 31, 2024
	Comment

Proportion of vaccines not wasted	Value	0.00	90.00	0.00
	Date	January 11, 2021	March 31, 2024
	Comment

Percentage of health facilities in the project area with functioning management committees having community representation	Value	80.00	95.00	0.00
	Date	January 11, 2021	March 31, 2024
	Comment

Number of solarized cold storage and health facilities	Value	605.00	2234.00	0.00
	Date	February 11, 2021	March 31, 2024
	Comment